Previous studies noted that the activation of PI3K/AKT/mTOR and Wnt/β-catenin [27,28] signaling pathways protects CRC and other tumors from toxic effects caused by chemotherapy agents [29,30]. This evidence concerns the gene MTOR and colorectal carcinoma.